文献速递心力衰竭与心肌病心律失常

遗传性心肌病:基因型与表型的预后预测比较

Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

该研究纳入281例(80%为扩张型心肌病)携带致病或可能致病变异的心肌病患者,比较基于表现型与基于基因型的分类对预后的预测能力。生存分析显示,基于基因型的分类可预测室性心律失常/心脏性猝死,而基于表现型的分类不能;LMNA变异在死亡/心脏移植及心衰相关终点上预后最差。

要点

  • 基因型分类对室性心律失常/心脏性猝死的预测优于表现型分类。
  • LMNA变异在死亡/心脏移植和心衰相关终点上预后最差。
  • 无扩张型心肌病表现型的患者室性心律失常/心脏性猝死事件更常见。

核心结论

  • 在遗传性心肌病中,基于基因型的分类比基于表现型的分类在预测患者结局方面精度更高。

研究设计与样本

  • 研究纳入281例(80%为扩张型心肌病)携带致病或可能致病变异的心肌病患者,涵盖扩张型心肌病、致心律失常性右心室心肌病、左优势型致心律失常性心肌病和双心室致心律失常性心肌病。

主要发现

  • 室性心律失常/心脏性猝死事件更常见于无扩张型心肌病表现型的患者以及DSP、PKP2、LMNA和FLNC变异携带者。
  • 调整年龄和性别后,基于基因型的分类可预测室性心律失常/心脏性猝死,而基于表现型的分类不能。
  • LMNA变异在死亡/心脏移植和心衰相关死亡/心脏移植/左心室辅助装置植入方面预后趋势最差。

临床怎么用

  • 对于基因检测阳性的心肌病患者,可依据基因型进行风险分层,以更精准地预测室性心律失常/心脏性猝死等结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diverse genetic backgrounds often lead to phenotypic heterogeneity in cardiomyopathies (CMPs). Previous genotype-phenotype studies have primarily focused on the analysis of a single phenotype, and the diagnostic and prognostic features of the CMP genotype across different phenotypic expressions remain poorly understood. OBJECTIVES: We sought to define differences in outcome prediction when stratifying patients based on phenotype at presentation compared with genotype in a large cohort of patients with CMPs and positive genetic testing. METHODS: Dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy, left-dominant arrhythmogenic cardiomyopathy, and biventricular arrhythmogenic cardiomyopathy were examined in this study. A total of 281 patients (80% DCM) with pathogenic or likely pathogenic variants were included. The primary and secondary outcomes were: 1) all-cause mortality (D)/heart transplant (HT); 2) sudden cardiac death/major ventricular arrhythmias (SCD/MVA); and 3) heart failure-related death (DHF)/HT/left ventricular assist device implantation (LVAD). RESULTS: Survival analysis revealed that SCD/MVA events occurred more frequently in patients without a DCM phenotype and in carriers of DSP, PKP2, LMNA, and FLNC variants. However, after adjustment for age and sex, genotype-based classification, but not phenotype-based classification, was predictive of SCD/MVA. LMNA showed the worst trends in terms of D/HT and DHF/HT/LVAD. CONCLUSIONS: Genotypes were associated with significant phenotypic heterogeneity in genetic cardiomyopathies. Nevertheless, in our study, genotypic-based classification showed higher precision in predicting the outcome of patients with CMP than phenotype-based classification. These findings add to our current understanding of inherited CMPs and contribute to the risk stratification of patients with positive genetic testing.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Paldino A, Dal Ferro M, Stolfo D, et al. Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies. J Am Coll Cardiol. 2022. PMID: 36396199. doi:10.1016/j.jacc.2022.08.804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。